SB 2081 In Committee
Insurance Companies, Agents, Brokers, Policies - As enacted, expands the prohibition, from stage 4 advanced metastatic cancer or metastatic blood cancer to any cancer, against a health benefit plan that provides coverage for cancer requiring the use of a step therapy protocol before the health benefit plan provides coverage for an approved prescription drug to an enrollee who has received a diagnosis of cancer. - Amends TCA Title 8; Title 56; Title 63; Title 68 and Title 71.
Introduced
In Committee
Floor
Crossed Over
Passed
Enacted
May 26, 2026 · House
Comp. became Pub. Ch. 995
Apr 20, 2026 · House
Sponsor(s) Added.
Apr 20, 2026 · House
Companion House Bill substituted
Apr 17, 2026 · House
Sponsor(s) Added.
Apr 17, 2026 · House
Placed on Senate Regular Calendar for 4/20/2026
Apr 17, 2026 · House
Placed on Senate Regular Calendar for 4/20/2026
Apr 7, 2026 · House
Recommended for passage, refer to Senate Calendar Committee
Apr 1, 2026 · House
Placed on Senate Commerce and Labor Committee calendar for 4/7/2026
Mar 10, 2026 · House
Action deferred in Senate Commerce and Labor Committee to 3/17/2026
Mar 4, 2026 · House
Placed on Senate Commerce and Labor Committee calendar for 3/10/2026
Mar 3, 2026 · House
Action deferred in Senate Commerce and Labor Committee to 3/10/2026
Feb 24, 2026 · House
Placed on Senate Commerce and Labor Committee calendar for 3/3/2026
Feb 5, 2026 · Senate
Passed on Second Consideration, refer to Senate Commerce and Labor Committee
Feb 2, 2026 · House
Introduced, Passed on First Consideration
Jan 22, 2026 · House
Filed for introduction